Lineage Cell Therapeutics, Inc. (LCTX) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Lineage Cell Therapeutics, Inc. (LCTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $318.8M, listed on AMEX, employing roughly 70 people, carrying a beta of 1.60 to the broader market. Lineage Cell Therapeutics, Inc. Led by Brian Culley, public since 1992-03-05.
Snapshot as of May 15, 2026.
- Spot Price
- $1.27
- Total OI
- 12.9K